Singapore: +65-85097465 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Zimbabwe: +263-735539685, 773876488


Advanced PG Diploma in Clinical Research &

Tags:Pharmacovigilance Training | Online Pharmacovigilance Course | Pharmacovigilance Program

The drug development industry is changing in a way where innovation and pharmacovigilance are not separate from one another. New business models are maturing leading to the development of new generation therapies and to a coexistence of these newer drugs and well known blockbuster treatments from the past.

Pharmacovigilance is now an essential component of the life cycle of almost all healthcare related products. This is because of a demand for safer and more effective drugs and changes in regulations applicable to their research, development and marketing.

Many global companies such as Pfizer, Quintiles, GlaxoSmithkline etc have developed their own pharmacovigilance centres in all major clinical research regions around the world including India. In addition, local drug companies in these regions are also stepping up their work in research and development for both promising new molecules as well as generics. An industry analysis carried out by Frost & Sullivan titled ‘World Pharmacovigilance Markets in Lifesciences’ has found that the while the global pharmacovigilance industry in 2008 was valued at US $1859.9 million it is estimated to touch US $2252.2 million by 2015. This business report also emphasizes the shifting focus of key drug companies towards outsourcing their pharmacovigilance functions to smaller specialized pharmacovigilance service providers. Developing regions such as India, Latin America etc are slowly becoming a hub for pharmacovigilance business.

In November 2004, the Indian ‘Central Drugs Standard Control Organization’ (CDSCO) launched the National Pharmacovigilance Program under the aegis of Directorate General of Health Services and the Union Ministry of Health and Family Welfare which has now been replaced by the Pharmacovigilance Program of India (PvPI) introduced in 2010.

At JLI we endeavor to develop clinical research and pharmacovigilance professionals who are equipped with the most relevant and up-to-date knowledge and skills. We achieve this goal through the diversity of our innovative and unique high quality online clinical research and pharmacovigilance training programs.

This Advanced Pharmacovigilance Training Course is an integrated program that will give you a methodical understanding of the key areas of drug development, clinical research processes, clinical trial management, and pharmacovigilance systems thus boosting your skills and knowledge to the level expected of a Clinical Research and Pharmacovigilance Professional. In addition to clinical trial management, this Advanced Pharmacovigilance Training Program trains students to put together, evaluate and organize data related to drug side effects so as to make regulatory decisions pertaining to marketed drugs. Both clinical research and pharmacovigilance are now generating a significant number of new exciting career opportunities.

The curriculum for the program - Advanced Post Graduate Diploma in Clinical Research & Pharmacovigilance (APGDCR-P) is extensive, has been developed and evaluated by experienced industry professionals and is fully endorsed by the clinical research industry. Not only is this program suitable for new graduates but also for working professionals who either wish to grow further in their clinical research and/or pharmacovigilance career, or those who wish to make a move to the clinical research or pharmacovigilance sector from any other related industry.

Program Structure

    program curriculum

The later part of the program may involve mock exercises concerned with a real-time role review of a Clinical Research & Pharmacovigilance Professional in different capacities.

Program duration

Self Paced 6 - 8 months (Maximum duration 24 months)

All participants registered in the Online Pharmacovigilance Training Course: Advanced Post Graduate Diploma in Clinical Research & Pharmacovigilance (APGDCR-P) are expected to spend at least 15 hours every week in the Online Virtual Campus.

Program Assessment

The program follows a continuous assessment process by the faculty. There is no final exam. Students are assessed based on three criteria:

One is passing the online MCQ tests that follow each lesson; second is the timely submission of assignments and third is the degree of participation in the instructor led online discussions within the JLI Virtual Campus.

Program Eligibility

The minimum eligibility criteria for Advanced Post-Graduate Diploma in Clinical Research & Pharmacovigilance (APGDCR-P) would include either of the following:

  • Any degree in Bioscience/Life Sciences such as Biochemistry, Microbiology, Genetics, Biotechnology, Botany, Zoology etc

  • Any degree in Medicine such as MBBS, BDS, BPT, BAMS, BHMS,, BUMS etc

  • Any degree in Pharmacy / Pharmaceutical Sciences

  • Any degree in Chemistry / Biostatistics / Bioinformatics

  • Any degree in Nursing / Allied Health.

  • Students in their final year of graduation for the above courses are also eligible to apply.

  • Candidates who lack the above mentioned educational prerequisite may be eligible to apply if they have some prior work experience in clinical research / allied areas upon recommendation of their supervisor. Please contact our admission representatives / counsellor for more information.

Program Fee

James Lind Institute is well known for its commitment to access and affordability. Please feel free to use our Program Fee Calculator below to calculate the program fee applicable to you for this Advanced Clinical Research & Pharmacovigilance Training Program.

If your country is not listed or should you not be able to determine the fee applicable to you please write to us at or get in touch with our live chat support available on this website.

For more information about how to apply please click here.

Program Support

Every participant registered in the Advanced Post-Graduate Diploma in Clinical Research & Pharmacovigilance Course is provided with a mentor throughout the program duration who is an experienced professional from the clinical research industry. The mentor can be contacted at any time via email or phone.

In addition to the mentor, the students can interact online with the faculty members and fellow students to network and to discuss important topics. The faculty promptly answers all questions related to the study in the Online Campus Tutoring Center (OCTC).

Towards the end of the program students are provided placement assistance and career development support via the “Student Success Team”. To know more about the “Student Success Team”, click here.

James Lind Institute Newsletter
James Lind Institute Youtube
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Facebook